Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 147, Issue 4, 2007, Pages 690-697

  Nishii, Naohito ^a   Takasu, Masaki ^a   Soe, Ok Kar ^a   Maeda, Sadatoshi ^b   Ohba, Yasunori ^b   Inoue Murayama, Miho ^b   Kitagawa, Hitoshi ^b  

^a GIFU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Adipocytes; Adipose tissue; cDNA cloning; Dogs; mRNA expression; Obesity; Peroxisome proliferator activated receptors; Polymorphism

Indexed keywords

COMPLEMENTARY DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; DOG; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; LARGE INTESTINE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPECIES COEXISTENCE; SPLEEN; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION;

CANIS FAMILIARIS;

EID: 34250327398     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2007.04.011     Document Type: Article

References (36)

1. Amri E.Z., Bonino F., Ailhaud G., Abumrad N.A., and Grimaldi P.A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270 (1995) 2367-2371
2. Björntorp P., Karlsson M., Pertoft H., Pettersson P., Sjöström L., and Smith U. Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J. Lipid Res. 19 (1978) 316-324
3. Braissant O., Foufelle F., Scotto C., Dauça M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
4. Butterwick R.F., and Hawthorne A.J. Advances in dietary management of obesity in dogs and cats. J. Nutr. 128 (1998) 2771S-2775S
5. Chawla A., Schwarz E.J., Dimaculangan D.D., and Lazar M.A. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135 (1994) 798-800
6. Cock T.A., Houten S.M., and Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep. 5 (2004) 142-147
7. Ding S.T., Schinckel A.P., Weber T.E., and Mersmann H.J. Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. J. Anim. Sci. 78 (2000) 2127-2134
8. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., and Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 224 (1996) 431-437
9. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., and Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142 (2001) 4195-4202
10. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
11. Houseknecht K.L., Bidwell C.A., Portocarrero C.P., and Spurlock M.E. Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARgamma). Gene 225 (1998) 89-96
12. Hu E., Tontonoz P., and Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9856-9860
13. Jiang J., Gajalakshmi V., Wang J., Kuriki K., Suzuki S., Nakamura S., Akasaka S., Ishikawa H., and Tokudome S. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. Cancer Sci. 96 (2005) 507-512
14. Kersten S. Peroxisome proliferator activated receptors and obesity. Eur. J. Pharmacol. 440 (2002) 223-234
15. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 (2000) 421-424
16. Lazar M.A. PPAR gamma, 10 years later. Biochimie 87 (2005) 9-13
17. Liu J., and Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279 (2004) 45020-45027
18. Liu K., Xu L., Berger J.P., Macnaul K.L., Zhou G., Doebber T.W., Forrest M.J., Moller D.E., and Jones A.B. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia. J. Med. Chem. 48 (2005) 2262-2265
19. Matsusue K., Peters J.M., and Gonzalez F.J. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. FASEB J. 18 (2004) 1477-1479
20. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Lebel P., Dallongeville J., Deeb S., Auwerx J., and Amouyel P. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 7 (1998) 435-440
21. Mori H., Ikegami H., Kawaguchi Y., Seino S., Yokoi N., Takeda J., Inoue I., Seino Y., Yasuda K., Hanafusa T., Yamagata K., Awata T., Kadowaki T., Hara K., Yamada N., Gotoda T., Iwasaki N., Iwamoto Y., Sanke T., Nanjo K., Oka Y., Matsutani A., Maeda E., and Kasuga M. The Pro12→Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50 (2001) 891-894
22. Nagasawa M., Ide T., Suzuki M., Tsunoda M., Akasaka Y., Okazaki T., Mochizuki T., and Murakami K. Pharmacological characterization of a human-specific peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in dogs. Biochem. Pharmacol. 67 (2004) 2057-2069
23. Nemoto S., Razeghi P., Ishiyama M., De Freitas G., Taegtmeyer H., and Carabello B.A. PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation. Am. J. Physiol., Heart. Circ. Physiol. 288 (2005) H77-H82
24. Nishizuka M. Cloning and characterization of inducible genes at the beginning of adipocyte differentiation. Yakugaku Zasshi 123 (2003) 949-956
25. Ramirez-Zacarias J.L., Castro-Munozledo F., and Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97 (1992) 493-497
26. Renaud J.P., and Moras D. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57 (2000) 1748-1769
27. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., and Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4 (1999) 611-617
28. Shen Z., Bakhtiar R., Komuro M., Awano K., Taga F., Colletti A., Hora D., Feeney W., Iliff S., Franklin R.B., and Vincent S. Enantiomer ratio of MK-0767 in humans and nonclinical species. Rapid Commun. Mass Spectrom. 19 (2005) 1125-1129
29. Song J., Sakatsume M., Narita I., Goto S., Omori K., Takada T., Saito N., Ueno M., and Gejyo F. Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. Clin. Genet. 64 (2003) 398-403
30. Tontonoz P., Graves R.A., Budavari A.I., Erdjument-Bromage H., Lui M., Hu E., Tempst P., and Spiegelman B.M. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res. 22 (1994) 5628-5634
31. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234
32. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
33. Uchino H., Kim T., Lam T.K., Yoshii H., Klement P., Williams W., Kawamori R., and Giacca A. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs. Metabolism 54 (2005) 1250-1258
34. Vidal-Puig A.J., Considine R.V., Jimenez-Liñan M., Werman A., Pories W.J., Caro J.F., and Flier J.S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99 (1997) 2416-2422
35. Wu P., Sato K., Yukawa S., Hikasa Y., and Kagota K. Differentiation of stromal-vascular cells isolated from canine adipose tissues in primary culture. J. Vet. Med. Sci. 63 (2001) 17-23
36. Yen C.J., Beamer B.A., Negri C., Silver K., Brown K.A., Yarnall D.P., Burns D.K., Roth J., and Shuldiner A.R. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem. Biophys. Res. Commun. 241 (1997) 270-274